Skip to main content
. 2016 May 11;22(6):497–510. doi: 10.1016/j.molmed.2016.04.007

Figure 4.

Figure 4

PTX3 as an Extrinsic Oncosuppressor in Cancer. In cancer, PTX3 gene and protein expression is controlled by the presence of inflammatory mediators (e.g., IL-1) and/or by genetic and epigenetic mechanisms. PTX3 regulates complement-dependent tumor-promoting inflammation in a host, including macrophage infiltration and cytokine production, as well as fibroblast growth factor (FGF)-dependent angiogenesis, which can lead to genetic instability and tumor promotion.